Claret Bioscience
We are an early-stage biotech startup based in Santa Cruz. We are a small, motivated, multi-disciplinary team innovating in NGS sequencing technologies and DNA assay design for applications in molecular diagnostics. At Claret Bioscience, we build NGS library preparation and analysis tools that empower a deeper understanding of degraded DNA molecules, with an emphasis on cell-free DNA (cfDNA). Our two main technologies are SRSLY and XACTLY. SRSLY, our Single Reaction Single-stranded DNA Library Prep Kit, produces complex libraries from 1ng of input cfDNA and is designed to capture a broad range of input molecule types. XACTLY, our novel dsDNA library prep, captures and encodes information about the termini of each molecule. To find out more click below or visit our technology pages.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Nationally (across the country)
About us
Degraded DNA molecules have a story to tell. And what good is any story without an end? Traditional Next Generation Sequencing (NGS) methods alter or obliterate the native ends of DNA fragments. But we at Claret Bioscience are nucleic acid purists. Our mission is to leave molecules unaltered and deliver the complete DNA story from beginning to end.